JF
KYNB

Jump Financial’s Kyntra Bio KYNB Stock Holding History

Jump Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-580
Closed -$12.9K – 1793
2024
Q2 		$12.9K Buy
+580
New +$17.9K ﹤0.01% 1722
2023
Q3 		– Sell
-558
Closed -$37.6K – 1971
2023
Q2 		$37.6K Sell
558
-1,609
-74% -$665K ﹤0.01% 1735
2023
Q1 		$1.01M Buy
+2,167
New +$1.15M 0.04% 592
2022
Q4 		– Sell
-568
Closed -$185K – 1718
2022
Q3 		$185K Buy
+568
New +$183K 0.01% 1362
2022
Q1 		– Sell
-1,361
Closed -$479K – 1657
2021
Q4 		$479K Sell
1,361
-2,491
-65% -$776K 0.03% 668
2021
Q3 		$984K Buy
+3,852
New +$1.36M 0.07% 296

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Jump Financial's KYNB Position: Q3 2024 in Review

Jump Financial sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 580 shares — an estimated $12.9K sold.

Jump Financial first reported a position in KYNB in Q3 2021 and held it in 6 quarters. The position peaked at $1.01M in Q1 2023. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Jump Financial reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 580 Kyntra Bio shares in Q3 2024, an estimated $12.9K.
  • Jump Financial first reported a position in Kyntra Bio in Q3 2021 and held it in 6 quarters.
  • Jump Financial's Kyntra Bio position peaked at $1.01M in Q1 2023.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.